Trade CureVac N.V. - CVAC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.93 |
| Open | 2.88 |
| 1-Year Change | -52.4% |
| Day's Range | 2.81 - 2.88 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 17, 2024 | 2.93 | -0.11 | -3.62% | 3.04 | 3.05 | 2.82 |
| Dec 16, 2024 | 3.08 | -0.01 | -0.32% | 3.09 | 3.17 | 3.06 |
| Dec 13, 2024 | 3.14 | 0.01 | 0.32% | 3.13 | 3.21 | 3.10 |
| Dec 12, 2024 | 3.17 | -0.07 | -2.16% | 3.24 | 3.25 | 3.16 |
| Dec 11, 2024 | 3.25 | 0.14 | 4.50% | 3.11 | 3.35 | 3.11 |
| Dec 10, 2024 | 3.18 | -0.23 | -6.74% | 3.41 | 3.48 | 3.14 |
| Dec 9, 2024 | 3.34 | 0.16 | 5.03% | 3.18 | 3.35 | 3.17 |
| Dec 6, 2024 | 3.09 | 0.04 | 1.31% | 3.05 | 3.22 | 3.00 |
| Dec 5, 2024 | 3.00 | 0.17 | 6.01% | 2.83 | 3.07 | 2.75 |
| Dec 4, 2024 | 2.86 | 0.07 | 2.51% | 2.79 | 2.89 | 2.76 |
| Dec 3, 2024 | 2.83 | -0.06 | -2.08% | 2.89 | 2.91 | 2.77 |
| Dec 2, 2024 | 2.89 | 0.00 | 0.00% | 2.89 | 2.93 | 2.85 |
| Nov 29, 2024 | 2.85 | 0.02 | 0.71% | 2.83 | 2.92 | 2.82 |
| Nov 27, 2024 | 2.84 | 0.11 | 4.03% | 2.73 | 2.91 | 2.73 |
| Nov 26, 2024 | 2.72 | 0.06 | 2.26% | 2.66 | 2.75 | 2.59 |
| Nov 25, 2024 | 2.73 | 0.11 | 4.20% | 2.62 | 2.79 | 2.62 |
| Nov 22, 2024 | 2.62 | 0.10 | 3.97% | 2.52 | 2.68 | 2.47 |
| Nov 21, 2024 | 2.54 | 0.06 | 2.42% | 2.48 | 2.57 | 2.39 |
| Nov 20, 2024 | 2.48 | -0.02 | -0.80% | 2.50 | 2.52 | 2.35 |
| Nov 19, 2024 | 2.48 | -0.07 | -2.75% | 2.55 | 2.63 | 2.47 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
CureVac N.V. Company profile
CureVac N.V. (CVAC) is a global clinical-stage biopharmaceutical company that develops medicines based on messenger ribonucleic acid (mRNA).
The company was founded in 2000 and is headquartered in Tübingen, Germany. It is listed on the NASDAQ stock exchange in August 2020 under the ticker symbol ‘CVAC.’
CureVac’s product portfolio is focused on oncology, infectious diseases and protein therapy. According to the company, its lead clinical programmes are CV8102 for the treatment of four types of solid tumours and CV7202 for potential vaccination against rabies.
The company has partnered with UK-based pharmaceutical firm GlaxoSmithKline (GSK) to develop second-generation mRNA vaccines for Covid-19 with the potential to address multiple emerging variants with one vaccine. CureVac’s first generation mRNA Covid-19 vaccine candidate CVnCoV is also under development.
CureVac N.V. and GSK are also developing an influenza vaccine together. Other vaccines currently under development are for yellow fever, respirational syncytial virus, rota, malaria and universal influenza.
According to the company’s prospectus, the company originally existed as CureVac AG. A Dutch private holding company CureVac B.V. was incorporated and CureVac AG was made a unit of the holding company. CureVac B.V. was then converted to a Dutch public company named CureVac N.V. The current chief executive of the company is Franz-Werner Haas.
According to the company’s price history, CVAC stock price hit an all-time high of $151.8 per share in December 2020. The company has not distributed dividends since going public.
You can follow the ups and downs of the CVAC share value at Capital.com. Always stay on top of the latest price developments with our live CVAC stock chart.
| Industry: | Biotechnology & Medical Research (NEC) |
Friedrich-Miescher-Str. 15
TUEBINGEN
BADEN-WUERTTEMBERG 72076
DE
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com